Elon Musk’s Neuralink plans a brain speech trial in October

Neuralink plans to begin another US clinical trial in October, using the implant to translate thoughts into text. The study will be held through an FDA investigational device exemption. “If you’re imagining saying something, we would be able to pick that up,” Neuralink president DJ Seo said this week.

The idea is to help people with speech impairments communicate through thought. Neuralink is among the companies testing implants that help patients control a computer with their minds. That can include…